Deprescribing Psychiatric Medication: 6 Essential Steps
Deprescribing psychiatric medication is the planned, supervised process of reducing or stopping a medication when it is safe and clinically appropriate to do so. Sometimes the medication that once helped no longer does. Sometimes the side effects have come to outweigh the benefits. And sometimes people simply want to know whether they still need what they are taking. Doing it properly matters as much as starting a medication properly — and Mindora Health provides supervised deprescribing in Wollongong and by telehealth, without a waitlist.
When deprescribing psychiatric medication may be considered
Deprescribing may be worth discussing if:
Deprescribing is recognised as good clinical practice when done carefully. The Australian Deprescribing Network brings together clinicians and researchers working on exactly this — reducing medicines that are no longer providing benefit, safely and with the patient.
Which medicines can be deprescribed?
We consider deprescribing psychiatric medication by class rather than by product, because the approach differs:
No medicine names are listed here deliberately; the right approach depends on your assessment, not the label.
Who deprescribing may not be suitable for
Deprescribing psychiatric medication is not appropriate for everyone, and we will be honest if we don’t think it is the right time. For some conditions — including bipolar disorder, schizophrenia and recurrent severe depression — continued medication is often the safest option, and stopping can lead to relapse with serious consequences. Recent instability, a recent hospital admission, high current stressors or limited supports can all make now the wrong moment even where the long-term goal is reasonable.
Decisions are individual, evidence-based and made with you, not for you. That is why every deprescribing request begins with a comprehensive assessment.
6 essential steps for deprescribing psychiatric medication safely
Close monitoring. Regular telehealth follow-ups — more frequent during the taper — to check for withdrawal effects and early signs of relapse. Prescriptions for the reduced doses are issued electronically.
Your GP is kept informed with your consent, so that everyone involved in your care is working from the same treatment plan.
Discontinuation symptoms versus relapse
The two are often confused, and telling them apart is a core part of supervised deprescribing. Discontinuation symptoms tend to appear within days of a dose reduction, are often physical as well as emotional (dizziness, nausea, “brain zaps”, sleep disturbance, irritability), and usually settle as the body adjusts or if the previous dose is briefly restored. Relapse tends to emerge more gradually — weeks later — and looks like the original condition returning. Monitoring closely lets us respond to each correctly rather than guessing.
Our approach to deprescribing psychiatric medication
Nurse Practitioners prescribe — and deprescribe — within their scope of practice under the Nursing and Midwifery Board of Australia’s Nurse Practitioner Standards for Practice. Some medications and some conditions require psychiatrist involvement in a deprescribing decision, and we will tell you if that applies to you.
Deprescribing sits naturally with our practitioner’s research background in addiction medicine and in the care of people with co-occurring mental health and substance use problems (Merrick et al., 2022) — areas where careful, monitored medication decisions and honest conversations about dependence, tolerance and withdrawal are central to good care. We take the same evidence-based, whole-person approach to reducing medication as we do to starting it. And where the right answer is to continue, we say so and manage it through medication management. Read about our practitioner.
Fees
| Appointment | Duration | Fee | Medicare rebate |
|---|---|---|---|
| Initial comprehensive assessment — evaluation and deprescribing plan | 60 min | $250 | $117.20 |
| Long follow-up — taper review and plan revision | 40 min | $150 | $75.60 |
| Standard follow-up — taper monitoring | 20 min | $100 | $52.55 |
| Brief follow-up — quick check-in during taper | 10 min | $50 | $27.80 |
